文献速递腹部技术与安全US

剪切波弹性成像作为临床显著性门静脉高压的定量生物标志物:系统综述与Meta分析

Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-03-23

该系统综述与Meta分析纳入截至2017年2月9日的9篇文献共746例患者,评估剪切波弹性成像(SWE)肝硬度测量以肝静脉压力梯度(HVPG)为参考标准诊断临床显著性门静脉高压(CSPH)的效能。汇总敏感度85%(95%CI 75-91%;I²=78.56%),特异度85%(95%CI 77-90%;I²=0%),AUC 0.88(95%CI 0.85-0.91),肝硬度与HVPG的汇总相关系数0.741(95%CI 0.658-0.825;I²=0%)。结果支持SWE作为CSPH诊断生物标志物的价值,但成像设备、协议、测量方法和 cutoff 值存在显著异质性,提示需要标准化。

要点

  • SWE诊断CSPH汇总敏感度85%、特异度85%、AUC 0.88(95%CI 0.85-0.91)。
  • 肝硬度与HVPG汇总相关系数0.741(95%CI 0.658-0.825)。
  • 设备、协议、测量方法和 cutoff 值异质性显著,提示需要标准化。

核心结论

  • 一致证据支持SWE作为CSPH的诊断生物标志物,应考虑将其纳入生物标志物资格认定过程和CSPH患者管理。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和EMBASE截至2017年2月9日的文献,纳入9篇文章共746例患者。
  • 纳入标准为以HVPG为参考标准、评估SWE肝硬度测量诊断CSPH效能的研究。

诊断标准与关键数值

  • SWE诊断CSPH的汇总敏感度85%(95%CI 75-91%;I²=78.56%),汇总特异度85%(95%CI 77-90%;I²=0%)。
  • SWE诊断CSPH的ROC曲线下面积0.88(95%CI 0.85-0.91)。
  • SWE肝硬度与HVPG测量的汇总相关系数0.741(95%CI 0.658-0.825;I²=0%)。

临床应用与阅片要点

  • 原文结论认为一致证据支持SWE作为CSPH的生物标志物,应考虑在生物标志物资格认定过程和CSPH患者管理中加以考虑。
  • 原文指出所用成像设备、协议、肝硬度测量方法和 cutoff 值存在显著异质性,提示需要标准化。

局限性

  • 成像设备、协议、肝硬度测量方法和所用 cutoff 值存在显著异质性,提示需要标准化。
  • 诊断效能汇总敏感度存在显著异质性(I²=78.56%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To qualify shear wave elastography (SWE) as a biomarker for clinically significant portal hypertension (CSPH) beyond proof of concept, we aimed to accumulate and summarize the current evidence through systematic review and meta-analysis.

MATERIALS AND METHODS: A computerized literature search was performed to identify studies from MEDLINE and EMBASE up to February 9, 2017. Studies on the diagnostic performance of liver stiffness measurements using SWE for CSPH with hepatic venous pressure gradient (HVPG) as the reference standard were included. Various aspects of SWE were comprehensively assessed. The summary diagnostic performance of SWE for the diagnosis of CSPH and the summary correlation coefficient between liver stiffness measured using SWE and HVPG were evaluated through a meta-analysis.

RESULTS: Nine articles (including 746 patients) were retrieved. The diagnostic performance of SWE for the diagnosis of CSPH was fairly good, with a summary sensitivity of 85% (95% CI, 75-91%; I2 = 78.56%) and summary specificity of 85% (95% CI, 77-90%; I2 = 0%); the area under the ROC curve was 0.88 (95% CI, 0.85-0.91). The summary correlation coefficient between liver stiffness and HVPG measurements was 0.741 (95% CI, 0.658-0.825; I2 = 0%). These results support the value of SWE as a diagnostic biomarker for CSPH. However, there was significant heterogeneity in the imaging devices, protocols, liver stiffness measurement methods, and cutoff values used, which suggests that standardization is required.

CONCLUSION: The consistent evidence favoring SWE as a biomarker for CSPH should be considered in the biomarker qualification process and management of patients with CSPH.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Suh CH, Kim KW, Park SH, et al. Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 29570374. doi:10.2214/AJR.17.18367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。